Design Therapeutics DSGN
NASDAQ DSGN
$10.74 -0.36 (-3.27%)
As of: Oct 21, 2026 · 3:45 PM EDT

Design Therapeutics (DSGN) Operating Margin (2020)

Updated

Design Therapeutics (DSGN) recorded Operating Margin of -11700.00% in Q4 2020, up 215.00 percentage points from the prior quarter.

Analysis

Design Therapeutics (DSGN) Operating Margin (2020) Analysis & Trends

For FY2020, Design Therapeutics reported Operating Margin of -3685.84%.

  • Quarterly Operating Margin has ranged from -11915.00% in Q3 2020 to -438.73% in Q1 2020 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -11915.00% (Q3 2020), -4719.35% (Q2 2020) and -438.73% (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn 28.21%
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn 37.86%
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn 20.57%
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn -133.21%
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 28.37%
10 Design Therapeutics 672.56 Mn -183.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -11,700.00%
Sep 30, 2020 -11,915.00%
Jun 30, 2020 -4,719.35%
Mar 31, 2020 -438.73%
API Access

Design Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=DSGN&period=max&api_key=YOUR_API_KEY